Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Xenetic Biosciences (XBIO) Shares Outstanding (Diluted Average) (2023 - 2025)

Xenetic Biosciences' Shares Outstanding (Diluted Average) history spans 3 years, with the latest figure at $1.7 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Diluted Average) rose 10.4% year-over-year to $1.7 million; the TTM value through Dec 2025 reached $1.7 million, up 10.4%, while the annual FY2025 figure was $1.7 million, 10.4% up from the prior year.
  • Shares Outstanding (Diluted Average) reached $1.7 million in Q4 2025 per XBIO's latest filing, up from $1.5 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $1.7 million in Q4 2025 to a low of $1.5 million in Q1 2023.
  • Average Shares Outstanding (Diluted Average) over 3 years is $1.5 million, with a median of $1.5 million recorded in 2024.
  • The largest YoY upside for Shares Outstanding (Diluted Average) was 10.4% in 2025 against a maximum downside of 0.03% in 2025.
  • A 3-year view of Shares Outstanding (Diluted Average) shows it stood at $1.5 million in 2023, then grew by 0.86% to $1.5 million in 2024, then increased by 10.4% to $1.7 million in 2025.
  • Per Business Quant, the three most recent readings for XBIO's Shares Outstanding (Diluted Average) are $1.7 million (Q4 2025), $1.5 million (Q3 2025), and $1.5 million (Q2 2025).